Pennsaid FDA Approval History
Last updated by Judith Stewart, BPharm on Jan 28, 2021.
FDA Approved: Yes (First approved November 4, 2009)
Brand name: Pennsaid
Generic name: diclofenac sodium
Dosage form: Topical Solution
Company: Nuvo Research Inc.
Treatment for: Osteoarthritis
Pennsaid is a topical non-steroidal anti-inflammatory drug (NSAID) used for the treatment of signs and symptoms of osteoarthritis of the knee.
Development timeline for Pennsaid
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.